Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PCI Biotech Holding ASA ( (DE:4QG) ) has issued an update.
Euronext Oslo Børs has placed PCI Biotech Holding ASA in its Recovery Box, a special listing compartment used when circumstances around an issuer make the pricing of its securities particularly uncertain. The company will remain there until the exchange determines that these uncertainties have been resolved and normal pricing conditions are restored.
Placement in the Recovery Box signals heightened risk and regulatory scrutiny for PCI Biotech’s shares, which may affect investor confidence, liquidity and valuation. The move underscores the exchange’s use of segmentations such as the Recovery Box and Penalty Bench to manage market integrity when issuers face serious uncertainty or fail to comply with listing rules.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norwegian biotechnology company listed on Euronext Oslo Børs. It focuses on developing technologies and treatments based on photochemical internalisation, targeting improved delivery of therapeutics for cancer and other serious diseases in global healthcare markets.
YTD Price Performance: -12.20%
Average Trading Volume: 214,503
Current Market Cap: NOK8.06M
For detailed information about 4QG stock, go to TipRanks’ Stock Analysis page.